P-33 Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetesdoi:10.1016/S0168-8227(08)70807-6Wenying Yang and Qiuhe Ji and Dalong Zhu and Jinkui Yang and Lulu Chen and Zhimin Liu and Demin Yu and Li Yan...
Yang WY,Ji QH,Zhu DL,et al.Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents. Chinese Medical Journal . 2009Thrice-daily biphasic insulin aspart 30 may be another therapeutic ...
Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents. Yang WY,Ji QH,Zhu DL,et al. Chinese Medical Journal . 2009Yang WY,Ji QH,Zhu DL,et al.Thrice-daily biphasic insulin aspa...